Dr. Andreas Roos wins Emerging Myologist of the Year Prize at WMS 2023

We are excited to congratulate Dr. Andreas Roos on winning the World Muscle Society’s (WMS) President’s Prize for Emerging Myologist of the Year!  

This award (formerly the President’s Prize for Young Myologist of the Year) recognizes outstanding contributions and innovation from an up-and-coming researcher in the field of myology. This year’s award highlights Dr. Roos’s exceptional portfolio of recent work, commending in particular his presentation at the conference on the identification of FILIP1 variants as a novel genetic cause for a neuropediatric disease with muscle involvement. Dr. Roos’s prolific output has resulted in a career total of almost 150 publications to date, and the FILIP1 manuscript is the latest of over 50 that Dr. Roos has published together with our group.  

Dr. Andreas Roos’s publication “Bi-allelic variants of FILIP1 cause congenital myopathy dysmorphism and neurological defects”

Dr. Roos is based at the Department of Neuropaediatrics of the Universitätsklinikum Essen in Germany and holds an adjunct professorship at uOttawa. He has been a long-time collaborator with our lab on joint projects on myotonic dystrophy, GNE myopathy, gene discovery and proteomic profiling in neuromuscular disease and has also consistently been involved in international research collaborations spanning a variety of diseases and techniques.

Congratulations Dr. Andreas Roos, World Muscle Society Emerging Myologist of the Year!

Dr. Andreas Roos receiving Emerging Myologist of the Year prize at World Muscle Society congress 2023.

Photo by World Muscle Society / World Muscle Society Congress 2023.

Dr. Andreas Roos receiving award on WMS 2023 stage, with text reading Congratulaions Dr. Andreas Roos, WMS President's Prize for Emerging Myologist of the Year 2023.

Read next...

Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...
New publication: Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis . Author's photos on the right, diagram from paper underneath title.

New Lab Publication Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis

Rhabdomyolysis is an acute failure of cellular homeostasis characterized by acute skeletal muscle damage triggered by trauma, infection, drugs, or strenuous exercise. Recurrent rhabdomyolysis is...
New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...
Congratulations CNMD Ottawa on 25 years of neuromuscular research. Photo of all former and current directors of the Centre.

uOttawa Eric Poulin Centre for Neuromuscular Disease Celebrates 25 Years of Neuromuscular Research

New co-directors Dr Mireille Khacho and Dr Hanns Lochmüller begin their tenure On November 25th the University of Ottawa Eric Poulin Centre for Neuromuscular Disease...
Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Dosed in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic...
New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers...